The review summarizes the outcomes of several landmark trials involving aromatase inhibitors that helped formulate current therapeutic approaches recommended by the American Society of Clinical Oncology for breast carcinoma treatment. © 2006 American Cancer Society.
CITATION STYLE
Gradishar, W. (2006, March 1). Landmark trials in endocrine adjuvant therapy for breast carcinoma. Cancer. https://doi.org/10.1002/cncr.21707
Mendeley helps you to discover research relevant for your work.